Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Britain Courts Anthropic Amid US Defense Department Dispute 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Apple Turns 50: From Garage Startup to AI Crossroads 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
, a range of dry surrogate microorganisms - EconoTimes)
DIJON, France, Oct. 07, 2016 -- Novolyze, a fast-growing food biotechnology company, announces the global launch of its new range of products: SurroNov(TM) www.novolyze.com
SurroNov(TM) is a range of innovative surrogate microorganisms that mimic the behavior of food pathogens (Salmonella, Listeria, Cronobacter sakazakii etc). As they are non-pathogenic, SurroNov(TM) products can be directly used in-plant to validate the efficacy of preventive controls on the microbial reduction of food products.
The range was officially presented at IAFP Annual Meeting in St. Louis. MO from July 29 to August 4, 2016. The first surrogate introduced is a strain used for the validation of low water activity foods (spices, nuts, powders, pet food etc) for which the prevention and control of microbiological hazards is a key food safety challenge. Our surrogate has been tested on numerous food processes, most of them thermal processes such as extruders, dryers, roasters and ovens. The first projects performed using SurroNov(TM) products showed highly correlative results, confirming the strong interest of the food industry for stabilized, dry & ready to use surrogate microorganisms.
The launch of SurroNov(TM) is an important step for Novolyze: It is the result of several years of R&D as well as intensive financial and human capital investments. SurroNov(TM) products are patented innovations based on Novolyze Dry Surrogate Technology. In parallel, the company continues its development plan, focused on the research of new strains for different kinds of food products.
Jena Robers, VP Business Development at Novolyze : 'First collaborations with several multinational food companies have been initiated and we are proud that our innovations received such a positive feedback. We are convinced that SurroNov(TM) surrogate microorganisms are a key tool for food companies to comply with FSMA Final Rule for Preventive Controls for Human Food. Our team is now focused on the evolution of the range and on the launch of other strains to complete our portfolio. Our ambition is to offer innovative solutions to our partners in order to better control microbiological hazards and improve food safety of processed foods.'
Contact :
Pierre-Olivier BEAL Business Development Manager
T (USA) : +1 (617) 500-8536
www.novolyze.com
